Clinical and pathologic characteristics of graft-versus-host disease produced in cyclophosphamide-treated adult mice
Sandberg, J.S.; Owens, A.H.; Santos, G.W.
Journal of the National Cancer Institute 46(1): 151-160
1971
ISSN/ISBN: 0027-8874 PMID: 4395991 Document Number: 44092
Document emailed within 1 workday
Related Documents
Ushiyama, C.; Hirano, T.; Miyajima, H.; Okumura, K.; Ovary, Z.; Hashimoto, H. 1995: Anti-IL-4 antibody prevents graft-versus-host disease in mice after bone marrow transplantation. The IgE allotype is an important marker of graft-versus-host disease Journal of Immunology 154(6): 2687-2696Via, C.S.; Rus, V.; Gately, M.K.; Finkelman, F.D. 1994: IL-12 stimulates the development of acute graft-versus-host disease in mice that normally would develop chronic, autoimmune graft-versus-host disease Journal of Immunology 153(9): 4040-4047
You-Ten, K.E.; Lapp, W.S. 1996: The role of endogenous glucocorticoids on host T cell populations in the peripheral lymphoid organs of mice with graft-versus-host disease Transplantation 61(1): 76-83
Divanian, K. 1986: Inhibition of the regional graft vs. host reaction in F1 mice preliminarily treated intrahepatically with semiallogeneic lymphocytes Eksperimentalna Meditsina i Morfologiia 25(4): 43-47
Zaleski, M. 1971: Effect of host-versus-graft and graft-versus-host reactions on the immune response of mice to sheep red blood cells Folia Biologica 17(2): 111-122
Atkinson, K.; Downs, K. 1995: Omission of day 11 methotrexate does not appear to influence the incidence of moderate to severe acute graft-versus-host disease, chronic graft-versus-host disease, relapse rate or survival after HLA-identical sibling bone marrow transplantation Bone Marrow Transplantation 16(6): 755-758
van den Brink, M.R.; Moore, E.; Horndasch, K.J.; Crawford, J.M.; Murphy, G.F.; Burakoff, S.J. 2000: Fas ligand-deficient gld mice are more susceptible to graft-versus-host-disease Transplantation 70(1): 184-191
Atkinson, K.; Storb, R.; Weiden, P.L.; Deeg, H.J.; Gerhard-Miller, L.; Thomas, E.D. 1980: In vitro tests correlating with presence or absence of graft-vs-host disease in DLA nonidentical canine radiation chimeras: evidence that clonal abortion maintains stable graft-host tolerance Journal of Immunology 124(4): 1808-1814
Van Rappard-Van der Veen, F.M.; Kiesel, U.; Poels, L.; Schuler, W.; Melief, C.J.; Landegent, J.; Gleichmann, E. 1984: Further evidence against random polyclonal antibody formation in mice with lupus-like graft-vs-host disease Journal of Immunology 132(4): 1814-1820
Nair, V.; Sharma, A.; Ghosh, I.; Arora, S.; Sahai, K.; Dutta, V. 2005: Extensive chronic graft-versus-host disease of skin successfully treated with thalidomide Journal of the Association of Physicians of India 53: 988-990
Acosta, A.; Infante, J.F.; Sarmiento, M.E.; Izquierdo, L.; Capó, V.; Dueñas, P.; Zamanillo, T.; Sierra, G. 1994: Sequential study of an experimental model of graft vs. host disease (GvHD) in non-immunosuppressed F1 (CBA/J x C57BL/6) mice Archives of Medical Research 25(2): 155-157
Brok, H.P.; Heidt, P.J.; van der Meide, P.H.; Zurcher, C.; Vossen, J.M. 1993: Interferon-gamma prevents graft-versus-host disease after allogeneic bone marrow transplantation in mice Journal of Immunology 151(11): 6451-6459
Xun, C.Q.; Thompson, J.S.; Brown, S.A.; Jennings, C.D.; Henslee-Downey, P.J. 1993: Acute graft-versus-host-like disease induced by human CD56+, CD16+, CD8-dim+ cells in SCID mice Transplantation Proceedings 25(1 Part 2): 1227-1229
Palathumpat, V.; Dejbakhsh-Jones, S.; Holm, B.; Strober, S. 1992: Different subsets of T cells in the adult mouse bone marrow and spleen induce or suppress acute graft-versus-host disease Journal of Immunology 149(3): 808-817
Nedelea, M.; Dima, S. 1975: Appearance of a syndrome similar to graft versus host reaction in C57 B1/6 mice bearing skin allogenic graft Morphologie et Embryologie 21(4): 299-304
De Ruysscher, D.; Sobis, H.; Vandeputte, M.; Waer, M. 1991: A subpopulation of asialo GM1-positive cells plays a protective role in the occurrence of graft-versus-host disease (GVHD) in mice Transplantation Proceedings 23(1 Part 1): 804
Hard, R.C. 1975: Hyperimmunoglobulinaemia, T-cell deficiency and plasmacytosis in RFM mice with host versus graft disease induced by the perinatal inoculations (T6XRFM)F1 spleen cells Clinical and Experimental Immunology 22(2): 330-340
Martin-Algarra, S.; Bishop, M.R.; Tarantolo, S.; Cowles, M.K.; Reed, E.; Anderson, J.R.; Vose, J.M.; Bierman, P.; Armitage, J.O.; Kessinger, A. 1995: Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxis Experimental Hematology 23(14): 1503-1508
Lehnert, S.; Rybka, W.B. 1994: Amplification of the graft-versus-host reaction by cyclophosphamide: dependence on timing of drug administration Bone Marrow Transplantation 13(4): 473-477
Vallera, D.A.; Taylor, P.A.; Vannice, J.L.; Panoskaltsis-Mortari, A.; Blazar, B.R. 1995: Interleukin-1 or tumor necrosis factor-alpha antagonists do not inhibit graft-versus-host disease induced across the major histocompatibility barrier in mice Transplantation 60(11): 1371-1374